Management tracks: bluebird's Walsh departing as chief strategy officer; plus JDRF, Akcea, Rigel, Elicio and Progenity

bluebird bio Inc. (NASDAQ:BLUE) Chief Strategy Officer Jeffrey Walsh will step down, effective Jan. 6, 2020. The gene therapy company said CFO Chip Baird and CBO Joanne Smith-Farrell will assume additional corporate development and strategic responsibilities.

The JDRF T1D Fund named Steven St. Peter as a managing director. He was a founder and CEO of animal health company Aratana Therapeutics Inc. ...